Physician

David Conner Benton, MD

According to 2025 Medicare claims, David Benton, MD (NPI: 1336346501) practices hematology/oncology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from Cumberland, ME. This provider's primary affiliated billing organization is MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (NPI: 1205896107; TIN: 010357684) and primary practice location at 04086-1773. Benton is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Community Care Partnership of Maine, LLC (ACO ID: A2831), and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Benton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 227,289 HCPCS/CPT codes, and received $4,894,088 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,756 prescription claims across 302 beneficiaries totaling $13,474,598 in drug costs, led by Revlimid (Lenalidomide). DME data shows 12 claims. Open Payments data shows 8 records totaling $201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,614,359 to $4,894,088. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,058,913 to $13,474,598. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,602 to $249.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.9M2015 Medicare payment: $2,614,359 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,580,597 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,390,642 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,979,703 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,863,795 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,656,369 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,497,315 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,139,641 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,709,215 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,894,088 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015759251,902$2,614,359
2016724300,625$3,580,597
2017573218,236$3,390,642
2018534184,158$2,979,703
2019508246,315$3,863,795
2020475250,463$4,656,369
2021468198,007$3,497,315
2022425213,852$4,139,641
2023379213,721$4,709,215
2024372227,289$4,894,088

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.7M$13M2015 Drug cost: $2,058,913 (USD; Tot_Drug_Cst)2016 Drug cost: $2,601,421 (USD; Tot_Drug_Cst)2017 Drug cost: $2,218,580 (USD; Tot_Drug_Cst)2018 Drug cost: $4,197,111 (USD; Tot_Drug_Cst)2019 Drug cost: $4,944,757 (USD; Tot_Drug_Cst)2020 Drug cost: $6,503,895 (USD; Tot_Drug_Cst)2021 Drug cost: $8,894,919 (USD; Tot_Drug_Cst)2022 Drug cost: $9,643,766 (USD; Tot_Drug_Cst)2023 Drug cost: $11,443,347 (USD; Tot_Drug_Cst)2024 Drug cost: $13,474,598 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152481,573$2,058,913
20162661,728$2,601,421
20172281,369$2,218,580
20182171,319$4,197,111
20192201,580$4,944,757
20201931,380$6,503,895
20212311,678$8,894,919
20222492,148$9,643,766
20232692,425$11,443,347
20243022,756$13,474,598

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.0K$9.9K2015 Medicare payment: $9,919 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,649 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,678 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $627 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,675 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R156$9,919
2016N/R96$5,649
2017N/R26$2,678
2018N/RN/RN/R
2019N/R12$627
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R12$1,675

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2771,135$89
82728Ferritin (blood protein) level103241$13
80053Blood test, comprehensive group of blood chemicals2281,108$10
36415Insertion of needle into vein for collection of blood sample2731,137$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2871,341$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide942,641$1,602,010
ErleadaApalutamide1033,180$1,509,488
NubeqaDarolutamide882,640$1,186,515
PomalystPomalidomide401,120$828,167
ImbruvicaIbrutinib421,400$818,522

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4152Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unitNN/R12$1,675

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$201ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Conner Benton, MD?

Tedicare shows public-source Medicare data for David Conner Benton, MD (NPI 1336346501), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Conner Benton, MD have ACO affiliation data?

David Conner Benton, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831), and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to David Conner Benton, MD?

David Conner Benton, MD is linked to MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (billing NPI 1205896107) in the available physician profile data.

Does David Conner Benton, MD have Open Payments data?

David Conner Benton, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.